Investigation of low dose cabazitaxel potential as microtubule stabilizer in experimental model of Alzheimer's disease: Restoring neuronal cytoskeleton.
CONCLUSION: The above findings suggested that CBZ at low dose show neuroprotective effects against ICV-STZ induced microtubule-associated tau protein hyperphosphorylation in rats and may be an effective agent for the preventive treatment of AD.
PMID: 33030130 [PubMed - as supplied by publisher]
Source: Current Alzheimer Research - Category: Neurology Authors: Duggal P, Jadaun KS, Siqqiqui EM, Mehan S Tags: Curr Alzheimer Res Source Type: research
More News: Alzheimer's | Brain | Cancer | Cancer & Oncology | Donepezil | Namenda | Neurology | Pathology | Study